FXR1
Basic information
Region (hg38): 3:180868141-180982753
Links
Phenotypes
GenCC
Source:
- myopathy, congenital proximal, with minicore lesions (Limited), mode of inheritance: AR
- myopathy, congenital, with respiratory insufficiency and bone fractures (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Congenital myopathy 9A; Congenital myopathy 9B, proximal, with minicore lesions | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal; Neurologic; Pulmonary | 30770808; 35393337 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FXR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 16 | 5 | 3 |
Variants in FXR1
This is a list of pathogenic ClinVar variants found in the FXR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-180912712-C-T | Benign (Aug 15, 2018) | |||
3-180912713-G-T | Myopathy, congenital, with respiratory insufficiency and bone fractures | Uncertain significance (May 02, 2023) | ||
3-180912715-C-T | Likely benign (Dec 01, 2022) | |||
3-180912721-C-T | Likely benign (Jun 01, 2022) | |||
3-180933327-C-T | Myopathy, congenital, with respiratory insufficiency and bone fractures;Myopathy, congenital proximal, with minicore lesions | Benign/Likely benign (Aug 01, 2024) | ||
3-180933362-C-G | Delayed gross motor development;Neonatal respiratory distress;Scoliosis | Uncertain significance (Jan 12, 2022) | ||
3-180933377-T-C | not specified | Uncertain significance (Sep 01, 2021) | ||
3-180947913-A-G | Congenital myopathy | Uncertain significance (Nov 16, 2020) | ||
3-180948422-A-G | Congenital myopathy | Uncertain significance (Nov 16, 2020) | ||
3-180948769-A-T | Benign (Dec 31, 2019) | |||
3-180949239-G-A | not specified | Uncertain significance (Sep 25, 2024) | ||
3-180949288-T-C | not specified | Uncertain significance (Jun 02, 2023) | ||
3-180951305-A-T | not specified | Uncertain significance (Oct 26, 2022) | ||
3-180951420-C-T | Benign/Likely benign (Nov 01, 2024) | |||
3-180961474-G-T | not specified | Uncertain significance (Apr 01, 2024) | ||
3-180961539-T-C | Benign (May 03, 2018) | |||
3-180963044-C-T | Likely benign (Aug 01, 2022) | |||
3-180963079-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
3-180963084-G-A | not specified | Uncertain significance (Jan 19, 2024) | ||
3-180968159-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
3-180968210-G-A | not specified | Uncertain significance (Sep 08, 2024) | ||
3-180971082-T-TG | Myopathy, congenital proximal, with minicore lesions | Pathogenic (Jul 16, 2024) | ||
3-180971083-GA-G | Myopathy, congenital proximal, with minicore lesions • Multiminicore myopathy | Uncertain significance (May 28, 2020) | ||
3-180971083-G-GA | Myopathy, congenital proximal, with minicore lesions | Pathogenic (Jul 16, 2024) | ||
3-180971145-TAGAC-T | Myopathy, congenital, with respiratory insufficiency and bone fractures | Pathogenic (Jul 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FXR1 | protein_coding | protein_coding | ENST00000357559 | 17 | 114613 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000327 | 125654 | 0 | 3 | 125657 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.20 | 182 | 351 | 0.519 | 0.0000194 | 4068 |
Missense in Polyphen | 56 | 152.31 | 0.36768 | 1715 | ||
Synonymous | 0.913 | 101 | 113 | 0.891 | 0.00000587 | 1170 |
Loss of Function | 5.69 | 1 | 39.7 | 0.0252 | 0.00000252 | 429 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000183 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein required for embryonic and postnatal development of muscle tissue. May regulate intracellular transport and local translation of certain mRNAs (By similarity). {ECO:0000250}.;
- Pathway
- RNA transport - Homo sapiens (human);Disease;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Diseases of signal transduction
(Consensus)
Recessive Scores
- pRec
- 0.194
Intolerance Scores
- loftool
- 0.425
- rvis_EVS
- -0.65
- rvis_percentile_EVS
- 16.36
Haploinsufficiency Scores
- pHI
- 0.833
- hipred
- Y
- hipred_score
- 0.777
- ghis
- 0.619
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.763
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fxr1
- Phenotype
- hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; immune system phenotype; muscle phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- fxr1
- Affected structure
- skeletal muscle myoblast
- Phenotype tag
- abnormal
- Phenotype quality
- circular
Gene ontology
- Biological process
- apoptotic process;muscle organ development;negative regulation of translation;cell differentiation;regulation of mRNA stability;positive regulation of translation;positive regulation of gene silencing by miRNA
- Cellular component
- nucleus;nucleolus;cytoplasm;cytosol;polysome;postsynaptic density;membrane;axon;ribonucleoprotein granule;cytoplasmic ribonucleoprotein granule;neuronal cell body;costamere;dendritic spine;perinuclear region of cytoplasm;glutamatergic synapse
- Molecular function
- RNA binding;mRNA binding;mRNA 3'-UTR binding;protein binding;RNA strand annealing activity;protein homodimerization activity;translation regulator activity;protein heterodimerization activity